CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 15 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $0 | – | 180 | +127.8% | 0.00% | – |
| Q3 2019 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 79 | +3.9% | 0.00% | – |
| Q1 2019 | $0 | – | 76 | -29.6% | 0.00% | – |
| Q4 2018 | $0 | – | 108 | -7.7% | 0.00% | – |
| Q3 2018 | $0 | – | 117 | -48.9% | 0.00% | – |
| Q2 2018 | $0 | – | 229 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 229 | -11.9% | 0.00% | – |
| Q4 2017 | $0 | – | 260 | +13.5% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 229 | -14.2% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 267 | -47.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 504 | +10.0% | 0.00% | – |
| Q4 2016 | $2,000 | -86.7% | 458 | -81.8% | 0.00% | – |
| Q3 2016 | $15,000 | +1400.0% | 2,514 | +997.8% | 0.00% | – |
| Q2 2016 | $1,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 21,000 | $28,000 | 0.00% |
| AJ WEALTH STRATEGIES, LLC | 12,677 | $17,000 | 0.00% |
| Virtu Financial LLC | 39,613 | $53,000 | 0.00% |
| BREWIN DOLPHIN LTD | 5,586 | $7,541 | 0.00% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 23 | $0 | 0.00% |
| UBS Group AG | 2,956 | $4,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,240 | $17,000 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $29,000 | 0.00% |